CSIMarket
 




Regencell Bioscience Holdings Limited  (NASDAQ: RGC)
Other Ticker:  
 
 





RGC Price to Earnings Ratio (Jun 30 2023)
Diluted EPS 12 Trailing Months IV. Quarter
PE (TTM) Ratio current            -            -            -            -            -
Diluted EPS TTM Y / Y Change - % - % - % - % - %
Diluted EPS Y / Y Change - % - % - % - % - %
Stock performance to date -49.54 %

Price to earnings ratio Comment
Regencell Bioscience Holdings Limited's recorded net loss in trailing twelve months.

Within Consumer Non Cyclical sector 5 other companies have lower Price to earnings ratio.

What is Price to Earnings Ratio?
What is Regencell Bioscience Holdings Limited Market Share?

Price to earnings ratio Company Ranking
Within: No.
Industry #1
Sector #6
S&P 500 #71





Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.